Results 31 to 40 of about 32,083 (123)
A Multicenter Cross-Sectional Study of the Swiss Cohort of LAMA2-Related Muscular Dystrophy. [PDF]
Background: LAMA2-related muscular dystrophy (LAMA2-RD) is an autosomal-recessive disorder and one of the most common congenital muscular dystrophies. Due to promising therapies in preclinical development, there is an increasing effort to better define ...
Enzmann C +14 more
europepmc +3 more sources
LAMA2‐related muscular dystrophy: Natural history of a large pediatric cohort
Abstract Objective To characterize natural history of Laminin‐α2 related muscular dystrophies (LAMA2‐RD) to help anticipating complications and identifying reliable outcome measures for clinical trial design and powering. Methods We conducted a retrospective, single‐center, cross‐sectional and longitudinal study on 46 LAMA2‐RD pediatric patients (37 ...
Alberto A. Zambon +6 more
wiley +1 more source
Diagnostic value of whole‐exome sequencing in Chinese pediatric‐onset neuromuscular patients
Our study achieved a diagnostic yield from WES of 26% (13/50). These cases were diagnostically challenging as prior investigations failed to give clues on specific genetic diagnosis. Our findings are compatible to previous studies observing the diagnostic yield tends to be lower in cohorts that have already undergone prior extensive evaluations ...
Mandy H. Y. Tsang +14 more
wiley +1 more source
Abstract Background Weakness is the primary impairment in paediatric neuromuscular diseases, impacting gait and gait‐related functional activities in ambulant children affected by these rare and often degenerative diseases. Gait speed is an indicator of health and disability, yet gait is a complex, multi‐faceted activity.
Rachel A. Kennedy +3 more
wiley +1 more source
Comprehensive target capture/next-generation sequencing as a second-tier diagnostic approach for congenital muscular dystrophy in Taiwan. [PDF]
PURPOSE:Congenital muscular dystrophy (CMD) is a heterogeneous disease entity. The detailed clinical manifestation and causative gene for each subgroup of CMD are quite variable.
Wen-Chen Liang +8 more
doaj +1 more source
Congenital muscular dystrophy (CMD) is a clinically and genetically heterogeneous group of inherited muscle disorders. In patients, muscle weakness is usually present at or shortly after birth and is progressive in nature.
Vandana A Gupta +10 more
doaj +1 more source
Impaired Regeneration in Dystrophic Muscle—New Target for Therapy
Muscle stem cells (MuSCs), known as satellite cells (SCs) have an incredible ability to regenerate, which enables the maintenance and growth of muscle tissue.
Nurit Yanay +5 more
doaj +1 more source
Characterizing the impact of LAMA2-deficiency in cancer cell lines
Tese de mestrado, Biologia Evolutiva e Desenvolvimento, 2023, Universidade de Lisboa, Faculdade de CiênciasAt the present time, cancer is a leading cause of death worldwide, according to the World Health Organization (WHO).
Fonseca, Inês Cardoso Ferreira Oliva da
core +2 more sources
Additional file 1: Supplemental Figure 1. Fibrosis is not significantly changed between immuno deficient and immuno competent LAMA2-CMD muscle. (A) Detection of sirius red stain in TA sections of wild type, NOD Scid, dyW and NODScid dyW mice. Quantification of hydroxyproline in quadriceps of male (N = 4, 6, 8, 5 respectively; p value < 0.05*, 0.004**
Barraza-Flores, Pamela +5 more
openaire +1 more source
Hypoglycemia in patients with congenital muscle disease
Background Only a few small studies have previously reported episodes of hypoglycemia in children with neuromuscular diseases; however, there has been no broader investigation into the occurrence of hypoglycemia in children with congenital muscle disease
Leslie H. Hayes +10 more
doaj +1 more source

